Related Experiment Video
Updated: Jun 2, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Considerations on the clinical application of the human papillomavirus vaccine in Spain
Javier Cortés1, Federico Martinón-Torres, José Manuel Ramón y Cajal
1Coordinator of the Spanish HPV Vaccine Group, Palma de Mallorca, Spain.
Abstract:
The circumstances that in the opinion of the authors influence the lower than expected uptake of the vaccine against human papillomavirus in Spain are analyzed. Among others, aspects related to doubts about efficacy and safety, the attitude of the Spanish health authorities or the role of media and the antivaccine groups, as well as the vaccination "culture" of the gynecologist, are discussed. The authors conclude that only with the coordinated effort of all involved bodies in the vaccination process (health authorities, scientific societies, social agents, media...) wide coverage of HPV vaccine will be achieved.
Related Concept Videos
Vaccinations
Vaccines
Smallpox
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Sexually Transmitted Infections
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
